• Aucun résultat trouvé

Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease

N/A
N/A
Protected

Academic year: 2021

Partager "Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease"

Copied!
9
0
0

Texte intégral

Loading

Figure

Table 2 Comparison Between At-Risk Subjects Requesting Presymptomatic Testing for ALS/FTD or HD During the Same Time Period

Références

Documents relatifs

In conclusion, the results of this project should help to (1) give a clear picture of ALS distribution over 10 French counties; (2) identify clusters where environmen- tal factors

The collection and processing system of the medical data based on cloud computing, IoT in medicine and anticipation system for the dete- rioration of the patient's state on the

Alexithymia in amyotrophic lateral sclerosis and its neural correlates.5. Alexithymia in amyotrophic lateral sclerosis and its

Figure 6.1: Altered expression of TBPH and the expression of alpha-synuclein directed through the ddc-Gal4 HL4.36 transgene does not affects longevity and climbing ability.. 114

The navigation system uses a set of relay images to enable the robot to reach a goal configuration expressed as a desired attitude of visual landmarks in the image plane.. This

Nonlinear Control for Urban Vehicles Platooning, Relying upon a Unique Kinematic GPS.. Jonathan Bom, Benoît Thuilot, François Marmoiton,

The question therefore addressed in this text, based on a field study of newborn screening for cystic fibrosis in France, is that of the link between the quest

Le comportement électrochimique du complexe 3 dans lequel le ligand salen a été greffé de façon covalente sur la face primaire d’une  -cyclodextrine montre un